MSCI Nordic Countries Index Rises 1.2% to 396.74, Led by Genmab’s 12.1% Gain

Genmab's outsized move is doing much of the index-level work here, and a single-name gain of that size in a relatively small index is worth treating with caution rather than as a broad Nordic signal. The more telling detail is that industrials, not healthcare, led among sectors, which suggests the advance has some breadth beneath the headline. Whether that sector leadership persists once the Genmab effect fades is the open question.